deferiprone has been researched along with Endomyocardial Fibrosis in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Endomyocardial Fibrosis: A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Deferiprone treatment reduced iron deposition and IR in DC rats except for blood glucose." | 1.46 | Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats. ( Bao, Y; Jia, X; Jin, Q; Li, L; Liu, R; Liu, X; Xie, R; Zou, C, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zou, C | 1 |
| Liu, X | 1 |
| Xie, R | 1 |
| Bao, Y | 1 |
| Jin, Q | 1 |
| Jia, X | 1 |
| Li, L | 1 |
| Liu, R | 1 |
1 other study available for deferiprone and Endomyocardial Fibrosis
| Article | Year |
|---|---|
Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats.
Topics: Animals; Deferiprone; Diabetic Cardiomyopathies; Dose-Response Relationship, Drug; Endomyocardial Fi | 2017 |